Altimmune, Inc.(ALT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ALT Altimmune, Inc.

已收盘 05-08 16:00:00 EDT

5.80

+0.44

+8.21%

盘后5.82

+0.02+0.34%

19:59 EDT

最高5.90	最低5.25	成交量261.10万
今开5.50	昨收5.36	日振幅12.13%
总市值4.47亿	流通市值4.43亿	总股本7,701万
成交额1,481万	换手率3.42%	流通股本7,634万
市净率3.62	ROE-59.86%	每股收益-1.34
52周最高11.16	52周最低3.55	市盈率-4.33
股息0.00	股息收益率0.00	ROA-36.85%

北京优虎网络科技有限公司

{"stockData":{"symbol":"ALT","market":"US","secType":"STK","nameCN":"Altimmune, Inc.","latestPrice":5.8,"timestamp":1746734400000,"preClose":5.36,"halted":0,"volume":2611027,"hourTrading":{"tag":"盘后","latestPrice":5.8199,"preClose":5.8,"latestTime":"19:59 EDT","volume":55489,"amount":321828.0731,"timestamp":1746748753803},"delay":0,"floatShares":76335159,"shares":77013658,"eps":-1.338795,"marketStatus":"已收盘","change":0.44,"latestTime":"05-08 16:00:00 EDT","open":5.5,"high":5.9,"low":5.25,"amount":14808238.581420999,"amplitude":0.121269,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.338795,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1746777600000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":5.36,"preHourTrading":{"tag":"盘前","latestPrice":5.56,"preClose":5.36,"latestTime":"09:29 EDT","volume":44099,"amount":242688.92422500002,"timestamp":1746710988510},"postHourTrading":{"tag":"盘后","latestPrice":5.8199,"preClose":5.8,"latestTime":"19:59 EDT","volume":55489,"amount":321828.0731,"timestamp":1746748753803},"volumeRatio":0.92604,"impliedVol":1.8464,"impliedVolPercentile":0.988},"requestUrl":"/m/hq/s/ALT","defaultTab":"news","newsList":[{"id":"2533195245","title":"Altimmune, Inc.盘中异动 快速拉升5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533195245","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533195245?lang=zh_cn&edition=full","pubTime":"2025-05-08 00:41","pubTimestamp":1746636098,"startTime":"0","endTime":"0","summary":"北京时间2025年05月08日00时41分，Altimmune, Inc.股票出现异动，股价大幅上涨5.17%。Altimmune, Inc.股票所在的生物技术行业中，整体跌幅为0.73%。Altimmune, Inc.公司简介：Altimmune Inc 是一家处于临床阶段的生物制药公司，专注于开发针对肥胖症、代谢性疾病和肝脏疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508004139aa2c863b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508004139aa2c863b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALT","BK4139","LU1878469433.USD","BK4599"],"gpt_icon":0},{"id":"2529922689","title":"Altimmune, Inc.盘中异动 急速拉升5.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529922689","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529922689?lang=zh_cn&edition=full","pubTime":"2025-04-23 21:31","pubTimestamp":1745415072,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日21时31分，Altimmune, Inc.股票出现波动，股价大幅拉升5.57%。截至发稿，该股报5.12美元/股，成交量5.5037万股，换手率0.07%，振幅0.41%。Altimmune, Inc.股票所在的生物技术行业中，整体涨幅为0.57%。Altimmune, Inc.公司简介：Altimmune Inc 是一家处于临床阶段的生物制药公司，专注于开发针对肥胖症、代谢性疾病和肝脏疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213112a463f911&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213112a463f911&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALT","LU1878469433.USD","BK4599"],"gpt_icon":0},{"id":"2529383675","title":"Altimmune, Inc.盘中异动 急速拉升5.16%报4.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529383675","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529383675?lang=zh_cn&edition=full","pubTime":"2025-04-21 22:32","pubTimestamp":1745245959,"startTime":"0","endTime":"0","summary":"北京时间2025年04月21日22时32分，Altimmune, Inc.股票出现波动，股价急速上涨5.16%。截至发稿，该股报4.79美元/股，成交量42.2259万股，换手率0.55%，振幅8.13%。Altimmune, Inc.股票所在的生物技术行业中，整体涨幅为0.04%。其相关个股中，Ocean Biomedical Inc C/Wts 14/02/2028 、Aptevo Therapeutics Inc.、Dogwood Therapeutics, Inc.涨幅较大，Aptevo Therapeutics Inc.、Transcode Therapeutics, Inc.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为1074.80%、907.52%、739.63%，振幅较大的相关个股有Geovax Labs Inc C/Wts 29/09/2025、Dogwood Therapeutics, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 ，振幅分别为106.34%、58.81%、43.24%。Altimmune, Inc.公司简介：Altimmune Inc 从事开发治疗肥胖症和肝病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421223239aa2c7467&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421223239aa2c7467&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU1878469433.USD","BK4599","ALT"],"gpt_icon":0},{"id":"2526861922","title":"Altimmune, Inc.盘中异动 下午盘股价大涨5.05%报4.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526861922","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2526861922?lang=zh_cn&edition=full","pubTime":"2025-04-12 01:53","pubTimestamp":1744394027,"startTime":"0","endTime":"0","summary":"北京时间2025年04月12日01时53分，Altimmune, Inc.股票出现异动，股价大幅拉升5.05%。截至发稿，该股报4.37美元/股，成交量76.3477万股，换手率0.99%，振幅5.89%。Altimmune, Inc.股票所在的生物技术行业中，整体涨幅为1.87%。其相关个股中，Protagenic Therapeutics Inc C/Wts 26/04/2026 、Portage Biotech Inc.、Theratechnologies Inc.涨幅较大，Hepion Pharmaceuticals, Inc.、Portage Biotech Inc.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为2122.14%、1676.89%、400.18%，振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 26/04/2026 、Portage Biotech Inc.、Theratechnologies Inc.，振幅分别为193.75%、156.27%、77.44%。Altimmune, Inc.公司简介：Altimmune Inc 从事开发治疗肥胖症和肝病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250412015347a6b8083f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250412015347a6b8083f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALT","LU1878469433.USD","BK4599","BK4139"],"gpt_icon":0},{"id":"2518682201","title":"Altimmune, Inc.盘中异动 下午盘急速跳水5.12%报5.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518682201","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518682201?lang=zh_cn&edition=full","pubTime":"2025-03-11 02:21","pubTimestamp":1741630882,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日02时21分，Altimmune, Inc.股票出现波动，股价大幅跳水5.12%。截至发稿，该股报5.29美元/股，成交量148.018万股，换手率1.92%，振幅4.90%。Altimmune, Inc.股票所在的生物技术行业中，整体涨幅为0.70%。其相关个股中，Mineralys Therapeutics, Inc.、Aeon Biopharma, Inc.、Checkpoint Therapeutics, Inc.涨幅较大，Aeon Biopharma, Inc.、Biodexa Pharmaceuticals Plc、Scisparc Ltd.较为活跃，换手率分别为5934.70%、3845.43%、1003.65%，振幅较大的相关个股有Aeon Biopharma, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Biodexa Pharmaceuticals Plc，振幅分别为90.44%、88.14%、59.34%。Altimmune, Inc.公司简介：Altimmune Inc 从事开发治疗肥胖症和肝病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031102212298a2d5af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031102212298a2d5af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALT","LU1878469433.USD","BK4599"],"gpt_icon":0},{"id":"2517430971","title":"Altimmune, Inc.2024财年实现净利润-95.06百万美元，同比减少7.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517430971","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517430971?lang=zh_cn&edition=full","pubTime":"2025-03-08 00:00","pubTimestamp":1741363235,"startTime":"0","endTime":"0","summary":"3月8日，Altimmune, Inc.公布财报，公告显示公司2024财年净利润为-95.06百万美元，同比减少7.47%；其中营业收入为20000.00美元，同比减少95.31%，每股基本收益为-1.34美元。从资产负债表来看，Altimmune, Inc.总负债15.80百万美元，其中短期债务279000.00美元，资产负债比为0.09，流动比率为0.14。机构评级：截至2025年3月8日，当前有8家机构对Altimmune, Inc.目标价做出预测，其中目标均价为22.38美元，其中最低目标价为12.00美元，最高目标价为28.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000046a2647e59&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000046a2647e59&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALT"],"gpt_icon":0},{"id":"2517319420","title":"Altimmune, Inc.盘中异动 股价大跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517319420","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517319420?lang=zh_cn&edition=full","pubTime":"2025-03-07 03:05","pubTimestamp":1741287928,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日03时05分，Altimmune, Inc.股票出现波动，股价大幅下挫5.07%。Altimmune, Inc.股票所在的生物技术行业中，整体跌幅为0.84%。其相关个股中，Plus Therapeutics, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Aeon Biopharma, Inc.、Plus Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为4920.76%、3757.89%、255.79%，振幅较大的相关个股有Surrozen Inc C/Wts 01/08/2031 、Plus Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.，振幅分别为125.28%、122.63%、71.44%。Altimmune, Inc.公司简介：Altimmune Inc 从事开发治疗肥胖症和肝病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307030529963c7cb5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307030529963c7cb5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALT","LU1878469433.USD","BK4139","BK4599"],"gpt_icon":0},{"id":"2516651619","title":"HC Wainwright & Co.：重申Altimmune(ALT.US)评级，由买入调整至买入评级, 目标价由12.00美元调整至12.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516651619","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516651619?lang=zh_cn&edition=full","pubTime":"2025-03-04 01:55","pubTimestamp":1741024555,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：重申Altimmune(ALT.US)评级，由买入调整至买入评级, 目标价由12.00美元调整至12.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/04015548498807.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ALT"],"gpt_icon":0},{"id":"2516580806","title":"Altimmune, Inc.盘中异动 股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516580806","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516580806?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:53","pubTimestamp":1741017238,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时53分，Altimmune, Inc.股票出现波动，股价急速下挫5.04%。截至发稿，该股报6.32美元/股，成交量54.6719万股，换手率0.77%，振幅5.19%。Altimmune, Inc.股票所在的生物技术行业中，整体跌幅为0.38%。其相关个股中，Bioxcel Therapeutics, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Radiopharm Theranostics Limited涨幅较大，Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为2916.94%、141.90%、133.69%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Pliant Therapeutics, Inc.，振幅分别为206.20%、70.53%、50.09%。Altimmune, Inc.公司简介：Altimmune Inc 从事开发治疗肥胖症和肝病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032353589637c135&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032353589637c135&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4599","ALT","LU1878469433.USD"],"gpt_icon":0},{"id":"2514385796","title":"Altimmune, Inc.盘中异动 早盘股价大涨6.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514385796","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514385796?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:35","pubTimestamp":1740666911,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时35分，Altimmune, Inc.股票出现波动，股价快速上涨6.06%。截至发稿，该股报6.30美元/股，成交量22.7561万股，换手率0.32%，振幅4.55%。Altimmune, Inc.股票所在的生物技术行业中，整体涨幅为0.45%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Pasithea Therapeutics Corp C/Wts 12/08/2026 、Alector, Inc.涨幅较大，Quoin Pharmaceuticals Ltd、Moleculin Biotech, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为430.02%、92.85%、67.12%，振幅较大的相关个股有Channel Therapeutics Corporation、Quoin Pharmaceuticals Ltd、Neurosense Therapeutics Ltd C/Wts 10/11/2026 ，振幅分别为16.42%、15.14%、14.83%。Altimmune, Inc.公司简介：Altimmune Inc 从事开发治疗肥胖症和肝病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223511abdf6f9a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223511abdf6f9a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4599","BK4139","ALT","LU1878469433.USD"],"gpt_icon":0},{"id":"1127825329","title":"Altimmune 2024年第四季度GAAP每股收益为$(0.33)，符合预期，收入同比下降至$5.00千，现金及短期投资$131.9百万","url":"https://stock-news.laohu8.com/highlight/detail?id=1127825329","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1127825329?lang=zh_cn&edition=full","pubTime":"2025-02-27 20:07","pubTimestamp":1740658067,"startTime":"0","endTime":"0","summary":"Altimmune报告2024年第四季度每股亏损为$，符合分析师的共识预期。公司本季度报告收入为$5.00千，与去年同期的$37.00千相比下降了86.49%。以上内容来自Benzinga Earnings专栏，原文如下：Altimmune  reported quarterly losses of $ per share which met the analyst consensus estimate. This is a 38.89 percent increase over losses of $ per share from the same period last year.  The company reported $5.00 thousand in sales this quarter. This is a 86.49 percent decrease over sales of $37.00 thousand the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Altimmune 2024年第四季度GAAP每股收益为$(0.33)，符合预期，收入同比下降至$5.00千，现金及短期投资$131.9百万","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALT"],"gpt_icon":0},{"id":"2514148800","title":"Altimmune, Inc.盘中异动 股价大跌5.07%报5.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514148800","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514148800?lang=zh_cn&edition=full","pubTime":"2025-02-26 00:32","pubTimestamp":1740501166,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日00时32分，Altimmune, Inc.股票出现异动，股价急速下跌5.07%。截至发稿，该股报5.80美元/股，成交量100.272万股，换手率1.41%，振幅6.87%。Altimmune, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Organovo Holdings, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Silexion Therapeutics Corp涨幅较大，Organovo Holdings, Inc.、Gt Biopharma, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为1390.94%、1116.23%、913.93%，振幅较大的相关个股有Organovo Holdings, Inc.、Silexion Therapeutics Corp、Abpro Holdings Inc C/Wts 12/11/2029 ，振幅分别为224.93%、87.83%、66.67%。Altimmune, Inc.公司简介：Altimmune Inc 从事开发治疗肥胖症和肝病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226003246abdc9ada&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226003246abdc9ada&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU1878469433.USD","BK4599","ALT"],"gpt_icon":0},{"id":"2513720245","title":"Altimmune, Inc.盘中异动 快速跳水5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513720245","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513720245?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:02","pubTimestamp":1740409376,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时02分，Altimmune, Inc.股票出现异动，股价大幅下挫5.02%。截至发稿，该股报6.11美元/股，成交量30.6286万股，换手率0.43%，振幅5.19%。Altimmune, Inc.股票所在的生物技术行业中，整体涨幅为0.24%。其相关个股中，Pepgen Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Avalo Therapeutics, Inc.涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为156.69%、69.94%、25.47%，振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 ，振幅分别为137.23%、55.69%、41.14%。Altimmune, Inc.公司简介：Altimmune Inc 从事开发治疗肥胖症和肝病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230256a2521c30&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230256a2521c30&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALT","LU1878469433.USD","BK4599","BK4139"],"gpt_icon":0},{"id":"2512193805","title":"Altimmune, Inc.盘中异动 大幅拉升5.02%报6.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512193805","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512193805?lang=zh_cn&edition=full","pubTime":"2025-02-19 01:53","pubTimestamp":1739901219,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日01时53分，Altimmune, Inc.股票出现波动，股价快速拉升5.02%。截至发稿，该股报6.69美元/股，成交量143.045万股，换手率2.01%，振幅5.02%。Altimmune, Inc.股票所在的生物技术行业中，整体涨幅为0.66%。其相关个股中，Aditxt, Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 、Allogene Therapeutics, Inc.涨幅较大，Aditxt, Inc.、Moleculin Biotech, Inc.、Solid Biosciences Inc.较为活跃，换手率分别为594.05%、191.57%、161.21%，振幅较大的相关个股有Estrella Immunopharma Inc C/Wts 29/09/2028、Abvc Biopharma, Inc.、Allogene Therapeutics, Inc.，振幅分别为148.75%、92.00%、79.17%。Altimmune, Inc.公司简介：Altimmune Inc 从事开发治疗肥胖症和肝病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219015340a24ad74f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219015340a24ad74f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4599","ALT","LU1878469433.USD"],"gpt_icon":0},{"id":"2510338592","title":"Altimmune, Inc.盘中异动 早盘股价大跌5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510338592","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510338592?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:41","pubTimestamp":1739284873,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时41分，Altimmune, Inc.股票出现异动，股价大幅下挫5.29%。截至发稿，该股报6.26美元/股，成交量19.2329万股，换手率0.27%，振幅3.48%。Altimmune, Inc.股票所在的生物技术行业中，整体跌幅为1.30%。其相关个股中，Dominari Holdings Inc.、Ocean Biomedical, Inc.、Lipella Pharmaceuticals Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为2242.92%、592.17%、230.89%，振幅较大的相关个股有Ocean Biomedical, Inc.、In8Bio, Inc.、Dominari Holdings Inc.，振幅分别为33.04%、31.80%、29.38%。Altimmune, Inc.公司简介：Altimmune Inc 从事开发治疗肥胖症和肝病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112241149881befc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112241149881befc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1878469433.USD","BK4599","ALT","BK4139"],"gpt_icon":0},{"id":"2509244146","title":"疑似AltLayer新多签地址从CEX提取3.99亿枚ALT，约合1982万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509244146","media":"金色财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509244146?lang=zh_cn&edition=full","pubTime":"2025-02-06 17:10","pubTimestamp":1738833022,"startTime":"0","endTime":"0","summary":null,"market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://x.com/OnchainLens/status/1887427368836604130","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinse_live","symbols":["BK4139","BK4599","ALT","LU1878469433.USD"],"gpt_icon":0},{"id":"2509280019","title":"Altimmune, Inc.盘中异动 股价大涨5.12%报6.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509280019","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509280019?lang=zh_cn&edition=full","pubTime":"2025-02-05 23:23","pubTimestamp":1738769008,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日23时23分，Altimmune, Inc.股票出现异动，股价大幅上涨5.12%。截至发稿，该股报6.98美元/股，成交量30.8819万股，换手率0.43%，振幅4.37%。Altimmune, Inc.股票所在的生物技术行业中，整体涨幅为1.45%。其相关个股中，Oragenics Inc.、Pasithea Therapeutics Corp.、Pasithea Therapeutics Corp C/Wts 12/08/2026 涨幅较大，Pasithea Therapeutics Corp.、Oragenics Inc.、60 Degrees Pharmaceuticals, Inc.较为活跃，换手率分别为3932.53%、1159.54%、674.29%，振幅较大的相关个股有Oragenics Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Scisparc Ltd.，振幅分别为59.80%、54.05%、41.46%。Altimmune, Inc.公司简介：Altimmune Inc 从事开发治疗肥胖症和肝病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205232329961912d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205232329961912d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4599","ALT","LU1878469433.USD"],"gpt_icon":0},{"id":"2508497481","title":"Altimmune, Inc.盘中异动 早盘急速下跌5.42%报6.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508497481","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508497481?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:35","pubTimestamp":1738593345,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时35分，Altimmune, Inc.股票出现异动，股价快速下跌5.42%。截至发稿，该股报6.28美元/股，成交量13.3915万股，换手率0.19%，振幅1.05%。Altimmune, Inc.股票所在的生物技术行业中，整体跌幅为0.36%。其相关个股中，Hcw Biologics Inc.、Gh Research Plc、Briacell Therapeutics Corp.涨幅较大，Hcw Biologics Inc.、Briacell Therapeutics Corp.、Cyclerion Therapeutics, Inc.较为活跃，换手率分别为353.88%、307.70%、144.53%，振幅较大的相关个股有Hcw Biologics Inc.、180 Life Sciences Corp C/Wts 07/11/2025、Invivyd, Inc.，振幅分别为57.23%、33.33%、27.90%。Altimmune, Inc.公司简介：Altimmune Inc 从事开发治疗肥胖症和肝病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020322354598796fb7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020322354598796fb7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1878469433.USD","BK4599","ALT","BK4139"],"gpt_icon":0},{"id":"2508943789","title":"Altimmune, Inc.盘中异动 下午盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508943789","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508943789?lang=zh_cn&edition=full","pubTime":"2025-02-01 03:47","pubTimestamp":1738352870,"startTime":"0","endTime":"0","summary":"北京时间2025年02月01日03时47分，Altimmune, Inc.股票出现波动，股价急速跳水5.00%。截至发稿，该股报6.65美元/股，成交量129.71万股，换手率1.82%，振幅5.54%。Altimmune, Inc.股票所在的生物技术行业中，整体涨幅为0.55%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Metsera, Inc.、Cyclerion Therapeutics, Inc.涨幅较大，Cyclerion Therapeutics, Inc.、Nls Pharmaceutics Ltd.、Silexion Therapeutics Corp较为活跃，换手率分别为2782.24%、2045.11%、205.46%，振幅较大的相关个股有180 Life Sciences Corp C/Wts 07/11/2025、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Seastar Medical Holding Corporation，振幅分别为121.11%、80.00%、69.36%。Altimmune, Inc.公司简介：Altimmune Inc 从事开发治疗肥胖症和肝病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020103475096150f48&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020103475096150f48&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALT","BK4599","LU1878469433.USD","BK4139"],"gpt_icon":0},{"id":"2503642251","title":"Altimmune, Inc.盘中异动 早盘股价大涨6.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503642251","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503642251?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:31","pubTimestamp":1736951471,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时31分，Altimmune, Inc.股票出现异动，股价急速上涨6.18%。截至发稿，该股报6.62美元/股，成交量12.7942万股，换手率0.18%，振幅0.90%。Altimmune, Inc.股票所在的生物技术行业中，整体涨幅为0.68%。其相关个股中，Os Therapies Incorporated、Generation Bio Co.、Exicure, Inc.涨幅较大，Windtree Therapeutics, Inc.、Os Therapies Incorporated、Phio Pharmaceuticals Corp.较为活跃，换手率分别为184.25%、56.33%、51.74%，振幅较大的相关个股有Os Therapies Incorporated、Klotho Neurosciences, Inc.、Vincerx Pharma, Inc.，振幅分别为18.99%、12.00%、10.72%。Altimmune, Inc.公司简介：Altimmune Inc 从事开发治疗肥胖症和肝病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011522311298673ac4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011522311298673ac4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4599","LU1878469433.USD","BK4139","ALT"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.altimmune.com","stockEarnings":[{"period":"1week","weight":0.021},{"period":"1month","weight":0.3467},{"period":"3month","weight":-0.2243},{"period":"6month","weight":-0.3021},{"period":"1year","weight":-0.2627},{"period":"ytd","weight":-0.2566}],"compareEarnings":[{"period":"1week","weight":0.0119},{"period":"1month","weight":0.1126},{"period":"3month","weight":-0.0745},{"period":"6month","weight":-0.0619},{"period":"1year","weight":0.0851},{"period":"ytd","weight":-0.0425}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Altimmune, Inc.于2005年4月25日根据特拉华州法律成立。该公司是一家临床阶段的生物制药公司，专注于开发肥胖和肝脏疾病的治疗方法。公司的主要候选产品pemvidutide（原名ALT-801）是一种GLP-1/胰高血糖素双受体激动剂，正在开发用于治疗肥胖和代谢功能障碍相关的脂肪性肝炎（“MASH”），以前称为非酒精性脂肪性肝炎（“NASH”）。","yearOnYearQuotes":[{"month":1,"riseRate":0.388889,"avgChangeRate":-0.008115},{"month":2,"riseRate":0.388889,"avgChangeRate":0.000059},{"month":3,"riseRate":0.388889,"avgChangeRate":-0.052418},{"month":4,"riseRate":0.388889,"avgChangeRate":-0.049636},{"month":5,"riseRate":0.5,"avgChangeRate":0.063467},{"month":6,"riseRate":0.411765,"avgChangeRate":0.016734},{"month":7,"riseRate":0.411765,"avgChangeRate":0.04705},{"month":8,"riseRate":0.411765,"avgChangeRate":0.108003},{"month":9,"riseRate":0.222222,"avgChangeRate":-0.121386},{"month":10,"riseRate":0.222222,"avgChangeRate":0.030284},{"month":11,"riseRate":0.388889,"avgChangeRate":-0.02446},{"month":12,"riseRate":0.555556,"avgChangeRate":0.21194}],"exchange":"NASDAQ","name":"Altimmune, Inc.","nameEN":"Altimmune, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.4","shortVersion":"4.33.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Altimmune, Inc.(ALT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Altimmune, Inc.(ALT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Altimmune, Inc.,ALT,Altimmune, Inc.股票,Altimmune, Inc.股票老虎,Altimmune, Inc.股票老虎国际,Altimmune, Inc.行情,Altimmune, Inc.股票行情,Altimmune, Inc.股价,Altimmune, Inc.股市,Altimmune, Inc.股票价格,Altimmune, Inc.股票交易,Altimmune, Inc.股票购买,Altimmune, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Altimmune, Inc.(ALT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Altimmune, Inc.(ALT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}